Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases

Class:IdLiteratureReference:9672946
_displayNameThe Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases
_timestamp2020-01-03 16:55:20
author[Person:9672941] Tatton, Louise
[Person:9672942] Morley, Gary M
[Person:9672945] Chopra, Rajesh
[Person:9672943] Khwaja, Asim
created[InstanceEdit:9672944] Rothfels, Karen, 2020-01-03
journalJ. Biol. Chem.
pages4847-53
pubMedIdentifier12475982
titleThe Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases
volume278
year2003
(literatureReference)[Reaction:9670414] KIT mutants bind SFKs [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases (9672946)